Literature DB >> 6025477

Renin release during acute reduction of arterial pressure in normotensive subjects and patients with renovascular hypertension.

Y Kaneko, T Ikeda, T Takeda, H Ueda.   

Abstract

In normotensive subjects, acute reduction of mean arterial pressure to from 60 to 75 mm Hg by infusion of sodium nitroprusside caused significant increase in renin activity of renal venous plasma and also in the renal-systemic difference of renin activity. At the same time, the products of the renal-systemic difference of renin activity and renal plasma flow increased significantly, whereas renin substrate activity of plasma was unchanged, indicating that there was an increase in renin release during reduction in pressure. Renin activity of renal venous plasma, expressed in logarithms, showed a significant correlation with the degree of reduction in pressure; an increase in renin activity became significant when mean arterial pressure was reduced to below a level of 70 to 75 mm Hg. There was a striking difference in the renal response to reduction in pressure between patients with renovascular hypertension and normotensive subjects. In 10 renovascular hypertensive patients, significant increase in renin release occurred from the involved kidney at mean arterial pressures ranging from 90 to 137 mm Hg; the threshold at which renin release increased was shifted to a range much higher than that in normotensive subjects. Furthermore, the magnitude of renin release from the involved kidney was significantly greater when compared to that in normotensive subjects. In contrast, in the contralateral uninvolved kidney, no significant release of renin was detected during reduction in pressure. The renal mechanism controlling renin secretion appears to be operative at higher systemic arterial pressure levels and with enhanced responsiveness in the involved kidney of renovascular hypertensive patients; the findings are consistent with the hypothesis that the renin-angiotensin system participates in maintaining hypertension in this disease.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025477      PMCID: PMC297073          DOI: 10.1172/JCI105571

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  STUDIES ON RENIN.

Authors:  E HAAS; H GOLDBLATT
Journal:  Biochem Z       Date:  1963

2.  RENAL BARORECEPTOR CONTROL OF ACUTE RENIN RELEASE IN NORMOTENSIVE, NEPHROGENIC AND NEUROGENIC HYPERTENSIVE DOGS.

Authors:  S L SKINNER; J W MCCUBBIN; I H PAGE
Journal:  Circ Res       Date:  1964-12       Impact factor: 17.367

3.  RELATIVE ROLES OF THE SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEMS IN THE REFLEX CONTROL OF HEART RATE.

Authors:  G GLICK; E BRAUNWALD
Journal:  Circ Res       Date:  1965-04       Impact factor: 17.367

4.  RENIN ACTIVITY IN BLOOD FROM PATIENTS WITH HYPERTENSION.

Authors:  O M HELMER
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

5.  Interrelationship of electrolytes, juxtaglomerular cells and hypertension.

Authors:  L TOBIAN
Journal:  Physiol Rev       Date:  1960-04       Impact factor: 37.312

6.  Pressor substances in kidneys of renal hypertensive rats with and without adrenals.

Authors:  F GROSS; P LICHTLEN
Journal:  Proc Soc Exp Biol Med       Date:  1958-06

7.  Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients.

Authors:  I H PAGE; A C CORCORAN; H P DUSTAN; T KOPPANYI
Journal:  Circulation       Date:  1955-02       Impact factor: 29.690

8.  Renin and angiotensin-like activity in renal lymph.

Authors:  A F LEVER; W S PEART
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

9.  Measurement of renin activity in human plasma.

Authors:  P T Pickens; F M Bumpus; A M Lloyd; R R Smeby; I H Page
Journal:  Circ Res       Date:  1965-11       Impact factor: 17.367

10.  Angiotensinase with a high degree of specificity in plasma and red cells.

Authors:  P A KHAIRALLAH; F M BUMPUS; I H PAGE; R R SMEBY
Journal:  Science       Date:  1963-05-10       Impact factor: 47.728

View more
  29 in total

1.  The effect of a protein-free diet on the renin-angiotensin system in the rat.

Authors:  S Sonkodi; P Bókay; O Rácz; F Biliczki
Journal:  Pflugers Arch       Date:  1976-05-12       Impact factor: 3.657

2.  Obituary: a tribute to Yoshihiro Kaneko, MD.

Authors:  Satoshi Umemura
Journal:  Hypertens Res       Date:  2016-08       Impact factor: 3.872

3.  Uterine blood flow and uterine renin secretion.

Authors:  T F Ferris; J H Stein; J Kauffman
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

4.  [Hepatic extraction and clearance of renin in liver cirrhosis].

Authors:  H Wernze; A Seki; K W Schneider; R Jesse
Journal:  Klin Wochenschr       Date:  1972-03-15

5.  [Changes of serum angiotensionogen concentration in acute hepatitis and liver cirrhosis].

Authors:  H Wernze; A Seki; H Michel
Journal:  Klin Wochenschr       Date:  1972-01-01

6.  [Concentration of renin substrate (angiotensinogen) in maternal and fetal blood].

Authors:  H Wernze; A Seki
Journal:  Klin Wochenschr       Date:  1972-04-15

7.  Plasma renin activity in acute poststreptococcal glomerulonephritis and the haemolytic-uraemic syndrome.

Authors:  H R Powell; E Rotenberg; A L Williams; D A McCredie
Journal:  Arch Dis Child       Date:  1974-10       Impact factor: 3.791

8.  Peripheral renal vascular disease in essential hypertension: hemodynamic, angiographic, and endocrine assessment.

Authors:  I P Arlart; J Rosenthal
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

9.  Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.

Authors:  M G Bianchetti; K Boehringer; P Weidmann; L Link; H Schiffl; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

10.  Plasma catecholamines, plasma renin activity and haemodynamics during sodium nitroprusside-induced hypotension and additional beta-blockage with bunitrolol.

Authors:  B Stanek; M Zimpfer; S Fitzal; G Raberger
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.